相关实验视频

Updated: Jul 18, 2025

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

一种新的EGFR变异EGFRx通过STAT5维持质母细胞的干细胞

Wei Huang¹, Jing Li², Hongtao Zhu³

¹Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

|August 24, 2023

概括

一种新的EGFR变体 (EGFRx) 特别表达在质母细胞干细胞 (GSC) 中,并驱动瘤生长. 针对EGFRx-STAT5信号提供了一个有前途的治疗策略,用于多种质母细胞瘤 (GBM).

科学领域:

在瘤学瘤学.
分子生物学分子生物学
神经瘤学神经瘤学

背景情况:

质母细胞瘤 (GBM) 是一种具有攻击性的脑瘤,其特征是质母细胞瘤干细胞 (GSC).
皮表皮生长因子受体 (EGFR) 改变在GBM中很常见,与预后不佳相关.
EGFR 变异在 GSC 维持和 GBM 进展中的特定作用仍然在很大程度上未知.

研究的目的:

为了识别和表征GSC中的新型EGFR变异.
阐明已识别的EGFR变异在GSC自我更新,增殖和瘤发生中的功能作用.
研究EGFR变异对GBM进展有所贡献的潜在分子机制,包括信号通路.

主要方法:

生物信息分析 (HISAT-StringTie-Ballgown) 和分子分析 (5'RACE,RT-PCR,北方斑点) 用于检测和验证EGFR变异.
功能性研究包括神经圈测试,细胞活力测试,内外移植和RNA-seq.
信号通路分析涉及西部涂抹,共免疫沉,免疫光,光酶记者测定和CUT&Tag.

主要成果:

发现了一种新的EGFR变异,称为EGFRx,并发现它在GSC中特别表达.
EGFRx缺少2-14的外因子,编码了一个缺少细胞外联体结合域的截断蛋白,并且在GBM中高度活跃.
EGFRx对于GSC自我更新,增殖和瘤发生至关重要,通过STAT5.5的构成性激活起作用.

结论:

通过STAT5激活,EGFRx在维持GSC表型方面发挥着至关重要的作用.
EGFRx-STAT5信号传递是质母细胞瘤进展的关键驱动因素.
向EGFRx-STAT5通路为GBM治疗提供了一个潜在的治疗策略.

关键词:

欧洲农业基金x 欧洲农业基金x 在GBMGBMGBMGBMGBM 在STAT5中,我们使用了STAT5.干细胞是干细胞的组成部分.

更多相关视频

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

相关概念视频

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...